title: ZRF4, a combi-molecule with increased efficacy as compared with the individual components in chronic lymphocytic leukemia lymphocytes in vitro.
authors.forename: L
authors.initials: L
authors.lastname: Amrein
authors.forename: Z
authors.initials: Z
authors.lastname: Rachid
authors.forename: B
authors.initials: B
authors.lastname: Jean-Claude
authors.forename: D
authors.initials: D
authors.lastname: Soulières
authors.forename: R
authors.initials: R
authors.lastname: Aloyz
authors.forename: L
authors.initials: L
authors.lastname: Panasci
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D018906:Antineoplastic Agents, Alkylating / Q000494:pharmacology; D001549:Benzamides; D049109:Cell Proliferation / Q000187:drug effects*; D002699:Chlorambucil / Q000494:pharmacology*; D004249:DNA Damage / Q000187:drug effects; D006801:Humans; D000068877:Imatinib Mesylate; D066298:In Vitro Techniques; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D010766:Phosphorylation / Q000187:drug effects; D010879:Piperazines / Q000494:pharmacology*; D016315:Proto-Oncogene Proteins c-abl / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000138:chemical synthesis / Q000494:pharmacology*; D014226:Triazenes / Q000138:chemical synthesis / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
chemical_list: D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D014226:Triazenes; C562198:ZRF4 compound; D002699:Chlorambucil; D000068877:Imatinib Mesylate; D016315:Proto-Oncogene Proteins c-abl